Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by JayjayUSA12007on Sep 03, 2020 9:47pm
227 Views
Post# 31508700

RE:RE:RE:Looks like Trogarzo has launched in Germany

RE:RE:RE:Looks like Trogarzo has launched in Germany
longterm56 wrote: Good question, Bucknelly.  The silence from the company is deafening ... how can this be "none-news" for a company who's stock is so beaten down?

   -LT

Bucknelly21 wrote: Why would they not do a pr for that?




You assumed that Tera BOD/Management wanted PPS to increase now. It may not be the case, unfortunately....
Why ? How would Thera grant low strike price for options given to BOD members and/or management team, if PPS skyrockets to the teen ?
We know that news about Phase 3 trial could break at any moment, and Wall Street people also knew that. So, why PPS is still low ? Why keep quiet on newsworthy event ? Is it incompetent PR, or is it intentiional ?

Bullboard Posts